2024
Factors influencing timely diagnosis in neurolymphomatosis
Doubrovinskaia S, Egert A, Karschnia P, Scheffler G, Traub B, Galluzzo D, Huttner A, Fulbright R, Baehring J, Kaulen L. Factors influencing timely diagnosis in neurolymphomatosis. Journal Of Neuro-Oncology 2024, 170: 309-317. PMID: 39115616, DOI: 10.1007/s11060-024-04792-2.Peer-Reviewed Original ResearchNon-Hodgkin's lymphomaPeripheral nervous systemDiagnostic intervalNon-Hodgkin lymphoma diagnosisSymptom onset to diagnosisCerebrospinal fluid examinationYale Cancer CenterPainful polyneuropathyAsymmetric neuropathyRare entityMedian intervalFluid examinationQuality control databaseDelayed diagnosisPrimary diseaseUnivariate analysisConventional CTDisease sitesNeurolymphomatosisNeuro-oncologyCancer CenterSecondary diseaseImaging modalitiesNeuroimaging findingsDiagnosis
2022
Cerebrospinal Fluid Lymphocytic Pleocytosis is Associated With Enhanced Blood-Brain Barrier Breakdown at the Time of Multiple Sclerosis Diagnosis (P15-4.007)
Sivakolundu D, Kopyto M, Hill K, Elhusseiny H, Fulbright R, Hafler D, Longbrake E. Cerebrospinal Fluid Lymphocytic Pleocytosis is Associated With Enhanced Blood-Brain Barrier Breakdown at the Time of Multiple Sclerosis Diagnosis (P15-4.007). Neurology 2022, 98 DOI: 10.1212/wnl.98.18_supplement.2811.Peer-Reviewed Original ResearchChapter 55 Non-neoplastic mass lesions of the central nervous system
Karschnia P, Omay S, Fulbright R, Baehring J. Chapter 55 Non-neoplastic mass lesions of the central nervous system. 2022, 795-808. DOI: 10.1016/b978-0-12-822835-7.00043-3.Peer-Reviewed Original ResearchNon-neoplastic mass lesionsCentral nervous systemMass lesionNervous systemNon-neoplastic lesionsInvasive diagnostic proceduresAnti-tumor treatmentSpecific imaging modalityMimic malignancyUnnecessary treatmentNeurosurgical interventionNeoplastic lesionsPatient managementAdvanced imagingAccurate diagnosisLesionsDiagnostic proceduresImaging modalitiesDiagnosisModalitiesTreatmentMalignancyPrognosisEtiology